SCHEMBL28042920

SCHEMBL28042920

COc1cccc2nc(F)ncc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.44
KCNH2 Q12809 2/20 0.44
NQO2 P16083 5/20 0.43
PDE3B Q13370 1/20 0.42
PDE3A Q14432 1/20 0.42
PKM P14618 2/20 0.41
POLB P06746 3/20 0.41
ALDH1A1 P00352 4/20 0.40
LMNA P02545 4/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
TSHR P16473 2/20 0.40
HSD17B10 Q99714 2/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
USP2 O75604 1/20 0.40
TP53 P04637 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31391352 0.81 EGFR (0.46) GRM5KCNH2NQO2PDE3BPDE3A
SCHEMBL5213685 0.81 EGFR (0.46) GRM5KCNH2NQO2PDE3BPDE3A
SCHEMBL25381297 0.79 ALDH1A1 (0.53) GRM5KCNH2NQO2PDE3BPDE3A
SCHEMBL10613423 0.79 GRM5 (0.44) GRM5KCNH2NQO2PDE3BPDE3A
SCHEMBL25337729 0.79 SMN1; SMN2 (0.46) GRM5KCNH2NQO2PDE3BPDE3A
Hydrochloric Acid SCHEMBL28044722 0.78 ALDH1A1 (0.51) GRM5KCNH2NQO2PDE3BPDE3A
SCHEMBL25381668 0.76 ELANE (0.41) GRM5KCNH2NQO2PDE3BPDE3A
SCHEMBL28146671 0.75 GRM5 (0.54) GRM5KCNH2NQO2PDE3BPDE3A
Hydrochloric Acid SCHEMBL28214494 0.72 MCHR1 (0.49) NQO2PDE3BPDE3APKMPOLB
SCHEMBL26317670 0.72 PDGFRA (0.47) PDE3BPDE3APKMALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105051018-A Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections JANSSEN R&D IRELAND 2015-11-11 CN disclosed